Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H.O.P.E. Lenses and Low-concentration Atropine for Myopia Control in Young Children
NCT07846787Not yet recruiting
- Start
- Sep 2026
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
Trial of NVK002 in myopia (3 arms). Primary endpoint: Spherical Equivalent Refractive Error at 12 months. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
NVK002
03
Conditions
myopia
Beyond the preview
Go deeper on NCT07846787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07846787.